HIV Lipodystrophy Syndrome Recruiting Phase 4 Trials for Lamivudine (DB00709)

Also known as: Lipodystrophy Syndrome, HIV / HIV-Associated Lipodystrophy / HIV Associated Lipodystrophy / HIV-Associated Lipodystrophy Syndrome / HIV Associated Lipodystrophy Syndrome / Lipodystrophy Syndrome Related to HIV Infection / HIV Lipodystrophy

IndicationStatusPhase
DBCOND0029932 (HIV Lipodystrophy Syndrome)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04904406Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected IndividualsTreatment
NCT04903847Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir DisproxilTreatment